Solid Biosciences Inc.
SLDB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001707502
No open-market purchases or sales by Solid Biosciences Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.14B in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Solid Biosciences Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 116 | 129 | +13 |
| Shares | 82.8M | 81.9M | −940.4K (−1.1%) |
| Value | $403.4M | $505.2M | +$101.8M (+25.2%) |
New holders (25)
Institutions that held Solid Biosciences Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (12)
Institutions that held Solid Biosciences Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Monashee Investment Management LLC | 2,165,000 | $10.5M |
| Bollard Group LLC | 361,660 | $1.76M |
| Blair William & Co | 165,700 | $807.0K |
| Jump Financial, LLC | 115,762 | $563.8K |
| Sphera Funds Management Ltd. | 50,190 | $244.4K |
| Polar Asset Management Partners Inc. | 43,500 | $211.8K |
| Wealthedge Investment Advisors, LLC | 30,855 | $150.3K |
| Mariner, LLC | 19,414 | $94.5K |
| SG Americas Securities, LLC | 13,086 | $64.0K |
| Raymond James Financial Inc | 2,835 | $13.8K |
| TD Waterhouse Canada Inc. | 180 | $827 |
| Clearstead Advisors, LLC | 9 | $44 |